Advertisement

The Pathology and Management of Intracranial Hypertension in Acute Liver Failure

  • N. Murphy

Abstract

Acute liver failure is a syndrome manifest by the rapid cessation of hepatic function in previously normal individuals. The rate of decline in function dictates the manner in which the syndrome manifests and influences the outcome. The etiology of the insult to the liver is the main influence on the rate of progression and the likelihood of spontaneous recovery [1].

Keywords

Traumatic Brain Injury Cerebral Edema Intracranial Hypertension Mean Arterial Blood Pressure Acute Liver Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O’Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342:273–275PubMedCrossRefGoogle Scholar
  2. 2.
    Bernal W (2003) Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis 23:227–237PubMedCrossRefGoogle Scholar
  3. 3.
    Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23:217–226PubMedCrossRefGoogle Scholar
  4. 4.
    Lucke B, Mallory t (1946) Fulminant form of epidemic hepatitis. Am J Pathol 22:867–945Google Scholar
  5. 5.
    Ware AJ, D’Agostino AN, Combes B (1971) Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 61:877–884PubMedGoogle Scholar
  6. 6.
    Hanid MA, Mackenzie RL, Jenner RE, et al (1979) Intracranial pressure in pigs with surgically induced acute liver failure. Gastroenterology 76:123–131PubMedGoogle Scholar
  7. 7.
    Wendon JA, Larsen FS (2006) Intracranial pressure monitoring in acute liver failure. A proce dure with clear indications. Hepatology 44:504–506PubMedCrossRefGoogle Scholar
  8. 8.
    Jacques Bernuau, Durand F (2006) Intracranial pressure monitoring in patients with acute liver failure: A questionable invasive surveillance. Hepatology 44:502–504CrossRefGoogle Scholar
  9. 9.
    Blei AT (2005) The pathophysiology of brain edema in acute liver failure. Neurochem Int 47: 71–77PubMedCrossRefGoogle Scholar
  10. 10.
    Norenberg MD, Rao KV, Jayakumar AR (2005) Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 20:303–318PubMedCrossRefGoogle Scholar
  11. 11.
    Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648–653PubMedCrossRefGoogle Scholar
  12. 12.
    Bhatia V, Singh R, Acharya SK (2005) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55:98–104PubMedCrossRefGoogle Scholar
  13. 13.
    Traber PG, Dal Canto M, Ganger DR, Blei AT (1987) Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 7:1272–1277PubMedCrossRefGoogle Scholar
  14. 14.
    Kato M, Hughes RD, Keays RT, Williams R (1992) Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 15:1060–1066PubMedCrossRefGoogle Scholar
  15. 15.
    Takahashi H, Koehler RC, Brusilow SW, Traystman RJ (1991) Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 261:H825–829PubMedGoogle Scholar
  16. 16.
    Cordoba J, Gottstein J, Blei AT (1996) Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 24:919–923PubMedGoogle Scholar
  17. 17.
    Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic reso nance study. Hepatology 37:420–428PubMedCrossRefGoogle Scholar
  18. 18.
    Jayakumar AR, Rao KV, Murthy ChR, Norenberg MD (2006) Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 48:623–628PubMedGoogle Scholar
  19. 19.
    Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS (2002) Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 36:1333–1340PubMedGoogle Scholar
  20. 20.
    Wendon JA, Harrison PM, Keays R, Williams R (1994) Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 19:1407–1413PubMedGoogle Scholar
  21. 21.
    Blei AT, Larsen FS (1999) Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 31:771–776PubMedCrossRefGoogle Scholar
  22. 22.
    Larsen FS, Adel Hansen B, Pott F (1996) Dissociated cerebral vasoparalysis in acute liver failure. A hypothesis of gradual cerebral hyperaemia. J Hepatol 25:145–151PubMedCrossRefGoogle Scholar
  23. 23.
    Aggarwal S, Obrist W, Yonas H, et al (2005) Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 11:1353–1360PubMedCrossRefGoogle Scholar
  24. 24.
    Shawcross DL, Davies NA, Mookerjee RP (2004) Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 39:471–475PubMedCrossRefGoogle Scholar
  25. 25.
    Strauss G, Hansen BA, Kirkegaard P, Rasmussen A, Hjortrap A, Larsen FS (1997) Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure. Hepatology 25:837–839PubMedCrossRefGoogle Scholar
  26. 26.
    Tofteng F, Larsen FS (2004) The effect of indomethacin on intracranial pressure, cerebral per fusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24:798–804PubMedCrossRefGoogle Scholar
  27. 27.
    Tofteng F, Larsen FS (2004) Management of patients with fulminant hepatic failure and brain edema. Metab Brain Dis 19:207–214CrossRefGoogle Scholar
  28. 28.
    Bernal W, Wendon J (2004) Intracranial hypertension in acute liver failure; prevalence and risk factors for development. Hepatology 40:162A–266ACrossRefGoogle Scholar
  29. 29.
    Boeckx NK, Haydon G, Rusli F, Murphy N (2004) Multiorgan failure is the commonest cause of death in fulminant hepatic failure: a single centre experience. Liver Int 24:702–703PubMedCrossRefGoogle Scholar
  30. 30.
    Jalan R (2003) Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis 23:271–282PubMedCrossRefGoogle Scholar
  31. 31.
    Makin AJ, Wendon J, Williams R (1995) A 7-year experience of severe acetominophen-induced hepatotoxicity (1987–1993). Gastroenterology 109:1907–1916PubMedCrossRefGoogle Scholar
  32. 32.
    Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jorgensen L, Larsen FS (2006) Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 26:21–27PubMedCrossRefGoogle Scholar
  33. 33.
    Wijdicks EF, Plevak DJ, Rakela J, Wiesner RH (1995) Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 70:119–124PubMedGoogle Scholar
  34. 34.
    Munoz SJ, Robinson M, Northrup B, et al (1991) Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 13:209–212PubMedCrossRefGoogle Scholar
  35. 35.
    Strauss G I, Hogh P, Knudsen GM, Hansen BA, Larsen FS (1999) Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure. Hepatology 30:1368–1373PubMedCrossRefGoogle Scholar
  36. 36.
    Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK (2005) Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 20:181–192PubMedCrossRefGoogle Scholar
  37. 37.
    Nortje J, Gupta AK (2006) The role of tissue oxygen monitoring in patients with acute brain injury. Br J Anaesth 97:95–106PubMedCrossRefGoogle Scholar
  38. 38.
    Ellis AJ, Wendon JA, Williams R (2000) Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 32:536–541PubMedCrossRefGoogle Scholar
  39. 39.
    Nielsen HB, Tofteng F, Wang LP, Larsen FS (2003) Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. J Hepatol 38: 188–192PubMedCrossRefGoogle Scholar
  40. 40.
    Strauss GI, Moller K, Holm S, Sperling B, Knudsen GM, Larsen FS (2001) Transcranial Dopplersonography and internal jugular bulb saturation during hyperventilation in patients with fulminant hepatic failure. Liver Transpl 7:352–358PubMedCrossRefGoogle Scholar
  41. 41.
    Blei AT, Olafsson S, Webster S, Levy R (1993) Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341:157–158PubMedCrossRefGoogle Scholar
  42. 42.
    The Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care (2000). Indications for intracranial pressure monitoring. J Neurotrauma 17:479–491Google Scholar
  43. 43.
    Vaquero J, Fontana RJ, Larson AM, et al (2005) Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11:1581–1589PubMedCrossRefGoogle Scholar
  44. 44.
    Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG (2003) Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9:138–143PubMedCrossRefGoogle Scholar
  45. 45.
    Keays RT, Alexander GL, Williams R (1993) The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 18:205–209PubMedCrossRefGoogle Scholar
  46. 46.
    Tandon BN, Joshi YK, Tandon M (1986) Acute liver failure. Experience with 145 patients. J Clin Gastroenterol 8:664–668PubMedCrossRefGoogle Scholar
  47. 47.
    Murphy N, Auzinger G, Bernel W, Wendon J (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39:464–470PubMedCrossRefGoogle Scholar
  48. 48.
    Murphy ND, Wendon J (1999) Serum sodium is inversely proportional to intracranial pres sure in acute liver failure. Crit Care 3(Supp 1):P220 (abst)Google Scholar
  49. 49.
    The Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care (2000) Guidelines for cerebral perfusion pressure. J Neurotrauma 17:507–511Google Scholar
  50. 50.
    Tofteng F, Larsen FS (2004) Management of patients with fulminant hepatic failure and brain edema. Metab Brain Dis 19:207–214CrossRefGoogle Scholar
  51. 51.
    Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A (2001) Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypo thermia. Hepatology 34:50–54PubMedCrossRefGoogle Scholar
  52. 52.
    Davis MH, Multimer D, Lowes J, Elias E, Neuberger J (1994) Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 343:1329–1330CrossRefGoogle Scholar
  53. 53.
    Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A (2004) Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127:1338–1346PubMedCrossRefGoogle Scholar
  54. 54.
    Wijdicks EF, Nyberg SL (2002) Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 34:1220–1222PubMedCrossRefGoogle Scholar
  55. 55.
    Strauss GI, Moller K, Larsen FS, Kondrup J, Knudsen GM (2003) Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transpl 9: 1244–1252PubMedCrossRefGoogle Scholar
  56. 56.
    The Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care (2000) Intracranial pressure treatment threshold. J Neurotrauma 17:493–495Google Scholar
  57. 57.
    Canalese J, Gimson AE, Davis C, Mellon PJ, Davis W, Williams R (1982) Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 23:625–629PubMedCrossRefGoogle Scholar
  58. 58.
    Ede RJ, Gimson AE, Bihari D, Williams R (1986) Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 2:43–51PubMedCrossRefGoogle Scholar
  59. 59.
    Bhatia V, Batra Y, Acharya SK (2004) Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol 41:89–96PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • N. Murphy
    • 1
  1. 1.Department of Intensive CareQueen Elisabeth HospitalBirminghamUK

Personalised recommendations